Akoya Biosciences
Marlborough, United States · Bioinformatics, Biotechnology, Genetics
Akoya Biosciences is The Spatial Biology Company®, dedicated to advancing human health by providing spatial phenotyping solutions that bring biological context to life. Through comprehensive single-cell imaging technologies, Akoya enables researchers to visualize how cells are organized and interact within tissues to drive disease progression and therapeutic response. Serving discovery, translatio
Key facts
- Headquarters
- Marlborough, United States
- Employees
- 235
- Industries
- Bioinformatics, Biotechnology, Genetics
- Status
- Private
- Website
- akoyabio.com
- Company page
Recent activity at Akoya Biosciences
Akoya Biosciences funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2018 | Venture | $24.5M |
| Jul 2017 | Venture | $9.0M |
Leadership
- Brian McKelligon, Executive Officer, Director
- Garry Nolan, Director
- Matthew Winkler, Director
- Robert Shepler, Director
- Thomas Raffin, Director
- Garry Nolan, Director
- Matthew Winkler, Director
- Robert Shepler, Director
- Thomas Raffin, Director
- Rob Hart, Executive Officer
- Rob Hart, Executive Officer
- Brian McKelligon, Executive Officer
Verified email and direct lines for Akoya Biosciences’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Akoya Biosciences in the news
- Companion diagnostic requirements for spatial biology using multiplex immunofluorescence and multispectral imaging - Frontiers (Feb 08, 2023)
- Akoya to Report Fourth Quarter and Full Year 2021 Financial - GlobeNewswire (Feb 22, 2022)
- Akoya Biosciences Announces Full Enrollment in the CODEX™ Early Access Program for Highly Multiplexed Tissue Analysis - PR Newswire (May 31, 2018)
- Multiplex Immunofluorescence and Multispectral Imaging: Forming the Basis of a Clinical Test Platform for Immuno-Oncology - Frontiers (Jun 27, 2024)
- Akoya Biosciences Unveils Comprehensive Roadmap of Innovations at Inaugural Spatial Day Event - GlobeNewswire (Dec 15, 2021)
- Akoya Reports 53% Revenue Growth in the Second Quarter of 2021 - GlobeNewswire (Aug 10, 2021)
- Akoya Biosciences Announces Commercial Launch of - GlobeNewswire (Jan 13, 2022)
- Akoya Biosciences Launches PhenoCode Signature Panels to - GlobeNewswire (Nov 07, 2022)
Companies similar to Akoya Biosciences
- GenePlanet · Bioinformatics, Biotechnology, Genetics, Health Care, Health Diagnostics
- Genoox · Bioinformatics, Biotechnology, Genetics, Health Care, Health Diagnostics
- Personalis · Bioinformatics, Biotechnology, Genetics, Health Care, Health Diagnostics
- Genomic Testing Cooperative · Bioinformatics, Biotechnology, Genetics, Health Care, Health Diagnostics
- Breakthrough Genomics · Bioinformatics, Biotechnology, Genetics, Health Care, Health Diagnostics
About Akoya Biosciences: questions and answers
What does Akoya Biosciences do?
Akoya Biosciences is The Spatial Biology Company®, dedicated to advancing human health by providing spatial phenotyping solutions that bring biological context to life. Through comprehensive single-cell imaging technologies, Akoya enables researchers to visualize how cells are organized and interact within tissues to drive disease progression and therapeutic response. Serving discovery, translatio
Where is Akoya Biosciences headquartered?
Akoya Biosciences is headquartered in Marlborough, United States.
How many employees does Akoya Biosciences have?
Akoya Biosciences has about 235 employees.
Has Akoya Biosciences raised funding?
Yes. Fundz has recorded 2 funding events for Akoya Biosciences. The most recent, $24.5M, was in Oct 2018.
What is the latest news on Akoya Biosciences?
On Jan 28, 2025, Akoya Biosciences Partners with Argonaut Manufacturing Services for IVD Assay Manufacturing Support.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy